Laurus Labs

INDIA

Total Medicines

Active

Dosage Forms

Countries

Zimbabwe (17) Tanzania (15) Rwanda (12) Zambia (10) Ghana (2)

Registration Status

Registered 37

PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) 17

3 months to expiry 1

Valid 1

Dosage Forms

TABLET, COATED; ORAL 15 Tablet, Film-coated 8 Film Coated Tablets 6 Film-coated Tablets 4 Film coated tablets 4 Film Coated Tablet 3 Tablets+ Filmcoated 2 Tablets 2

Local Agents / Applicants

LAURUS LABS LIMITED 39

Laurus Labs Limited 9

Lupin Limited 1

Laurus labs Ltd 1

LAURUS LABS Limited, 2ND... 1

LAURUS LABS LIMITED, INDIA 1

Registered Medicines

Showing 20 of 56 · Page 1 of 3

Search all

Product	Form / Strength	Country	Reg. Number	Status
ABACAVIR AND LAMIVUDINE TABLETS 600MG/300MG Abacavir Sulphate and Lamivudine USP 600mg/300mg	Film-Coated Tablets 600mg/300mg	Rwanda	Rwanda FDA-HMP-MA-0936	Registered
ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE	TABLET, COATED; ORAL 600; 50; 300MG	Zimbabwe	2021/7.13/6216	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
ABACAVIR,DOLUTEGRAVIR AND LAMUVIDINE ABACAVIR,DOLUTEGRAVIR AND LAMUVIDINE	Film Coated Tablets 600MG/50MG/300MG	Rwanda	Rwanda FDA-HMP-MA-1453	Registered
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE TABLETS Abacavir Sulfate/Dolutegravir Sodium/Lamivudine	Abacavir Sulfate/Dolutegravir Sodium/Lamivudine 600mg/50mg/300mg	Ghana	FDA/GD.253-110222	Valid
ABACAVIR; LAMIVUDINE ABACAVIR; LAMIVUDINE	TABLET, COATED; ORAL 600; 300MG	Zimbabwe	2024/7.13/6629	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
Abacavir and Lamivudine Tablets USP 600 mg/300 mg Abacavir Sulphate 600 mg/6 mL,Lamivudine 300.000 mg/6 mL,Magnesium Sterate (Ligamed MF-2-V) 19.500 mg/6 mL,Microcrystalline cellulose (Ceolus UF 711) 297.720 mg,Opadry Orange YS-1-13065-A 34.375 mg,Purified Water. Q.S mg/6 mL,Sodium Starch Glycolate Type- A (Primojel) 55.000 mg	Oral tablet 600/300	Tanzania	TAN 23 HM 0188	Registered/Compliant
Abacavir, Dolutegravir and Lamivudine Abacavir, Dolutegravir and Lamivudine tablets	Dispersible tablet 60/5/30 mg	Rwanda	RWANDA-FDA25/HM/0312/0045	Registered
Abacavir, Dolutegravir and Lamivudine Abacavir sulfate equivalent to Abacavir 600 mg,Colloidal Silicon Dioxide (Aerosil-200) 8.00 mg,Dolutegravir Sodium equivalent to Dolutegravir 50 mg,Lamivudine 300 mg,Magnesium stearate (Ligamed MF-2-V) 28.5 mg,Mannitol (Pearlitol 50 C) 132.38 mg,Microcrystalline cellulose (Ceolus UF 711) 194.00 mg,Microcrystalline cellulose PH 101 166.72 mg,Opadry II Red 85F550060 41.75 mg/6 mL,Povidone K -30 (Kollidon 30) 20.00 mg,Purified Water q.s ml,Sodium Starch glycolate (Type A) (Primojel) 65.00 mg	Film coated tablets	Tanzania	TAN 23 HM 0055	Registered/Compliant
Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension 60mg/5mg/30mg Abacavir, Dolutegravir and Lamivudine	TABLET FOR ORAL SUSPENSION 60mg/5mg/30mg	Rwanda	RWANDA-FDA25/HM/0051/0041	Registered
Atazanavir and Ritonavir Tablets 300 mg/100 mg Atazanavir sulfate 300 mg/6 mL,Colloidal Silicon Dioxide (Aerosil-200) 13.800 mg/6 mL,Copovidone (plasdone S 630) 493.100 mg/6 mL,Crospovidone (Kollidon CL) 16.220 mg,Dicalcium phosphate anhydrous/Calcium hydrogen phosphate (A Tab) 83.550 mg/6 mL,Ferric oxide (Iron Oxide Sicovit yellow 10E172 0.200 mg/6 mL,Lactose Monohydrate (Flowlac 100) 27.000 mg/6 mL,Lactose Monohydrate (Granulac 200) 133.450 mg,Magnesium Sterate (Ligamed MF-2-V) 5.400 mg/6 mL,Opadry 03G520048 Yellow 30.000 mg/6 mL,Purified Water qs ml,Ritonavir 100 mg/6 mL,Sodium Stearyl Fumarate 7.650 mg/6 mL,Sorbitan Monolaurate (Span 20) 66.700 mg/6 mL	Tablet, Film-coated	Tanzania	TAN 24 HM 0032	Registered/Compliant
Atazanavir and Ritonavir tablets 300 mg/100 mg Atazanavir sulfate 341.710 mg,Ritonavir 100.00 mg	Film-coated Tablets 100.00 mg,341.710 mg	Zambia	ZAMRA-HM-25-259	Registered/Compliant
DARUNAVIR DARUNAVIR	TABLET, COATED; ORAL 400MG	Zimbabwe	2020/7.13/5961	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
DARUNAVIR DARUNAVIR	TABLET, COATED; ORAL 600MG	Zimbabwe	2020/7.13/5962	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
DARUNAVIR DARUNAVIR	TABLET, COATED; ORAL 800MG	Zimbabwe	2020/7.13/5963	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
DOLUTEGRAVIR 50MG TABLETS Dolutegravir Sodium 50 mg	Film coated Tablets 50 mg	Rwanda	Rwanda FDA-HMP-MA-1164	Registered
DOLUTEGRAVIR SODIUM DOLUTEGRAVIR SODIUM	TABLET, COATED; ORAL 50MG	Zimbabwe	2019/7.13/5923	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS Dolutegravir Sodium, Lamivudine and Tenofovir Alafenamide Fumarate 50 mg/300 mg/25 mg	Film Coated Tablets 50 mg/300 mg/25 mg	Rwanda	Rwanda FDA-HMP-MA-0935	Registered
DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE Dolutegravir sodium 50 mg, Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg	Film coated tablets 50mg/300mg/300mg	Rwanda	Rwanda FDA-HMP-MA-0937	Registered
DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFANAMIDE	TABLET, COATED; ORAL 50; 200; 25MG	Zimbabwe	2023/7.13/6493	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL 50; 300; 300MG	Zimbabwe	2019/7.13/5803	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)

1 2 3 Next

56 products